Four pharmaceutical companies on Thursday announced investments in Mexico of more than 12 billion pesos (US $641.45 million).

The Food and Drug Administration (FDA) is launching a new program to ramp up the United States’s domestic pharmaceutical ...

Global Capability Centres are driving innovation worldwide and they play to Singapore's strengths Read more at ...

The U.S. Food and Drug Administration (FDA) on Thursday announced FDA PreCheck, a program developed in response to a recent executive order signed by President Donald Trump to encourage domestic drug ...

In line with the Trump administration’s goal to curb the U.S.’ reliance on overseas drug manufacturing, the FDA has deployed ...

President Donald Trump notched his 200th day back in office Thursday, with the administration celebrating a lengthy list of wins across its latest chapter of actions and policies unfolding at a ...

Pharma giants AstraZeneca, Bayer and Boehringer Ingelheim on Thursday announced investments in Mexico worth hundreds of ...

Based on current deployment trends, the International Energy Agency expects greenhouse gases from data centre energy ...

The enhanced structure includes the addition of three C-level roles — chief innovation officer, chief client officer and ...

Tariffs would disrupt international supply chains, forcing companies to decide whether to pass on increased costs to patients ...

Increasing urbanisation is linked to a decline in crucial pollinator populations, including nocturnal moths, hoverflies, and ...

Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.